HSPG2 and cancer: It is possible that the physical activity induced release of LG3 peptide/endorepellin, and other similar anti-angiogenic fragments of ECM components, may be one of the physiological mechanisms for the well documented but still not clearly understood link between physical activity and reduced cancer risk or improved survival from cancer [63], [64], [65].